Does histopathological examination of breast reduction specimens affect patient management and clinical follow up? - Wikidata - wikimedia - TriplyDB

Does histopathological examination of breast reduction specimens affect patient management and clinical follow up?

Does histopathological examination of breast reduction specimens affect patient management and clinical follow up?

http://www.wikidata.org/entity/Q35587486

about

Mammoplasty for symmetry in breast reconstruction and histologic assessment.Histopathological evaluation of reduction mammaplasty specimens to detect occult breast cancer: a report from southern iran.The management of incidental findings of reduction mammoplasty specimens.Breast lesions in reduction mammaplasty specimens: a histopathological pattern in 534 patients.Radiologically innocuous breast reduction specimens. Should we send them to pathology lab anyway?Should we be analysing breast reduction specimens? A systematic analysis of over 1,000 consecutive cases.Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens.Adverse Histopathology and Imaging Findings in Reduction Mammaplasty Day-surgery Patients.Incidental breast carcinoma in reduction mammoplasty.Occult breast cancer in breast reduction specimens.Reduction mammoplasty is beneficial in women with and without history of breast cancer.Drs. Horo, Acker and Body reply.

P2860

Q35014403-41840210-B4F1-4BD9-9F9E-3AAED05A5FBD Q35131193-5D5C0C8D-797B-4D50-B0F1-F1E16E81AFE7 Q37543518-C1615368-5326-419A-A94D-EFA018F3C1C3 Q37558929-88638EF7-9D35-4BE6-9141-C918950FDD55 Q37588468-502F1CD9-2B73-48A8-84F4-89025F8DFBA7 Q38017089-54C29A28-05D3-40F2-A905-E398E0D01137 Q38845987-44459ACA-A7F5-42BA-8155-0D2215F3ED06 Q39232565-565DD6DC-82DF-4046-8D98-DA8AF1A3100A Q39370229-1A4C6481-7AB9-4984-BD86-85349ECCCE13 Q50087327-E8832C3B-B0AA-4A8D-900D-19096566599D Q53394330-FBABE1E4-B6E1-46F9-9ED0-62B595DE4091 Q55398330-E1B56CE8-6DE6-4D81-9225-EDF229C60989

P2860

Does histopathological examination of breast reduction specimens affect patient management and clinical follow up?

http://www.wikidata.org/entity/Q35587486

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Does histopathological examina ...... gement and clinical follow up?

@ast

Does histopathological examina ...... gement and clinical follow up?

@en

type

label

Does histopathological examina ...... gement and clinical follow up?

@ast

Does histopathological examina ...... gement and clinical follow up?

@en

prefLabel

Does histopathological examina ...... gement and clinical follow up?

@ast

Does histopathological examina ...... gement and clinical follow up?

@en

P1433

Q35587486-510F1C15-2450-4E1B-8BC2-85C7D5DAA63E

P1476

Q35587486-AEAC8BFD-956D-45D4-AB2C-167F51C8EA3F

P2093

Q35587486-10DFCDA7-A6D4-4C35-9B37-6B0EFC513202

Q35587486-259FFE69-9B64-4D7D-BDFD-5E5EB2340709

P2860

Q35587486-05D26593-1CBE-465F-8311-E321A2840BCA

Q35587486-1BB43F61-5274-4514-A3CE-2DF71535FA34

Q35587486-20224539-142E-4C0A-92B6-7F596B5A7544

Q35587486-2EB96313-3154-4084-9836-898E93843D79

Q35587486-5B0FA318-8062-485B-8E68-177C2B416EFA

Q35587486-82D110B0-CE85-4206-BCA1-438799AA2F11

Q35587486-95DF7321-4662-47F8-92A0-7578A86675C1

Q35587486-AC822653-AFCD-4B0C-AED0-B9AE66941EBF

Q35587486-CB00ADB9-B287-4313-8858-1692382491D5

Q35587486-CDAF685D-905E-4D78-85B8-66D7ADEF5D06

P304

Q35587486-03B8C633-B22A-4425-9455-DA19DBD68A71

P31

Q35587486-473910D1-7CE5-46BD-BC82-F9B25F7D9625

P356

Q35587486-A3376341-02D5-4303-B1D8-68DBAEA400AC

P407

Q35587486-1798CB84-5BC2-413E-8F31-D69FA874C0A2

P433

Q35587486-AB913069-3DC7-4511-A87A-AD67F55CF291

P478

Q35587486-8D16371E-C8C8-4457-916E-C23AE3025B79

P577

Q35587486-B9008168-525E-4B1D-A0BD-568202828A68

P5875

Q35587486-6A6F92EF-4196-4BC5-BBCA-9FEB61C17BE5

P698

Q35587486-932A1419-6244-44B0-A145-6CC84686CE5A

P921

Q35587486-8FF2CE9B-DBB9-417F-AFDB-2225EF61F62E

P932

Q35587486-B911D4DB-CB68-486F-A8EA-57D7C069198E

P356

JCP.2003.012427

P1433

Journal of Clinical Pathology

P1476

Does histopathological examina ...... gement and clinical follow up?

@en

P2093

Cook IS

http://www.w3.org/2001/XMLSchema#string

Fuller CE

http://www.w3.org/2001/XMLSchema#string

P2860

The transition from hyperplasia to invasive carcinoma of the breast.

Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology.

The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention.

Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?

Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.

Evaluation and management of high risk and premalignant lesions of the breast.

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.

Breast cancer in reduction mammoplasty: case reports and a survey of plastic surgeons.

Premalignant conditions and markers of elevated risk in the breast and their management.

A prospective study of benign breast disease and the risk of breast cancer.

P304

286-289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCP.2003.012427

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6237953

http://www.w3.org/2001/XMLSchema#string

P698

14990601

http://www.w3.org/2001/XMLSchema#string

P921

P932

1770254

http://www.w3.org/2001/XMLSchema#string